伟杰信生物

伟杰信生物

伟杰信生物

Biotech/Healthcare

Beijing Weijiexin Biotechnology focuses on reproductive hormone drug R&D, developing hormone therapies for both veterinary and human use. Its business covers recombinant drugs for human reproduction, recombinant drugs for animal reproduction, and reproductive health technical services and clinical…

Latest round: Series C (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-05-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.